Technetium tc 99m fanolesomab
As of the edition of 20 October 2026, Technetium tc 99m fanolesomab is an antibody: withdrawn from the market in 2005; US protection ended in 2016.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Withdrawn from market, 2005
- Kind
- Antibody
- Brand name
- NeutroSpec
- First approved
- 2 July 2004 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Palatin Technologies
- Withdrawn from market
- 1 January 2005 (in some regions)
US protection
US protection ended in 2016.
US protection ended in 2016, computed as 12 years from the first US licence because FDA publishes no date for this product. The application that gives this date is held by Palatin Technologies. The date is computed, not published.
This is the US only, and it is not the date generics or biosimilars can enter.
The exact date and the listings behind it
In the product1 listing counts towards this date. The exact date and each listing are in the product.
See the exact date and the 1 listing behind itRequest access. Nothing is shown until you do.